AMNIOCENTESIS

a diagnostic technique for

withdrawing amniotic fluid from
uterine cavity using a needle via a
transabdominal approach.

Indication:
DIAGNOSTIC : prenatal genetic studies, fetal infection, degree of
hemolytic anemia, blood type, hemoglobinopathy, and neural tube
defects.
THERAPEUTIC: remove excess fluid , volume or pressure
When is it done?
11-14 weeks: determine genetic anomalies, higher risk for complications
15-20 weeks: detect chromosomal abnormalities, evaluate fetal condition
after 35 weeks : assess fetal lung maturity

Client Education
Before the procedure:
Explain the purpose and the process .
Discuss its potential complications , accuracy and limitations.
Empty bladder to avoid risk of bladder puncture.

After the procedure:

Assessment of fetal status through electronic fetal and uterine
monitoring.
Client to report: persistent loss of vaginal fluid or bleeding, severe
uterine cramping for several hours and fever.
Nonalloimmunized RhD- negative clients should receive Rh D immune
globulin (RhoGAM) intramuscularly to prevent RhD sensitization.

During the Procedure

Position: Dorsal Lithotomy.

Ultrasound guided procedure.
Disinfect abdomen.
Maintain a sterile area.
Aspirate aseptically.
Fluid sent to lab